Member Info for inanaco

"We saw a good performance at Easter across all our channels and were pleased by our customers' response to our new spring seasonal lines. However, sales of our all year-round products in the Commercial channel were lower as the difficult consumer environment continues. "We continue to focus on restoring profitability and we are seeing early signs of progress resulting in an overall satisfactory trading performance."

It has not made a loss

at 30p its allowed

that last buy at 24.95 was me, i dont know how i got that price lol i think mm took it as a sale.. not a buy, looks like they need stock as the bids climbing quite quick

pity i cant spell thorntons !!

Judith McKenna, chair of the CBI distributive trades panel and Asda chief operating officer, said: The situation on our high streets remains fragile. Consumers are still holding off from buying bigger ticket items, and opting to spend on smaller 'treat' purchases that give them a lift without breaking the budget. If as expected, inflation falls further later this year, we may see some growth in retail sales, but as long as high unemployment and sluggish wage growth dampen confidence, spending will remain tight.

I dont see 4,000,000 dumped onto the market m8 the share price would be 5p !!

well buy em ... just bought up another £1500 thats it now all in.. on the market some cheap shares today lol 24.88 is cheap thanku

oversold now strong buy at this level chaps

just spotted the fall topped up... take a look at supergroup just bought in there 40% drop for minor accountant error lol

yea agree MM take the mick... but at 21p i paid, it was cheap... not looking to trade it this one will stay untill dividend pays on scancell ...

whats sparked the sudden interest here with a 10% jump

yea funny, but why someone pay 30p against ask of 26p ? you bought in then m8 what price you pay here

wait the update and hold the stock... because it would be impossible to calculate, and they may have hedged the wrong way ! who knows ...

Nice buy there million shares at 13p thats shows confidence !

SCLP thanku Lucinda for the post ..SCLP I'm glad we have a new near term of 36p from Shri9. That's a relief! The advice from the wise is "there is a bid coming." In the meantime the price will take its upward course until an offer price is known. As many have pointed out. Scancell has a FOR SALE sign attached to it. I see our lovely CEO Lindy Durrant has been appointed to Biovest International's Scientific Advisory Board. Now Ladies and Gentlemen that's one company that might just swallow up Scancell for starters, that is its parent might, Accentia Biopharmaceuticals, Inc. They have a cancer vaccine in Phase III to combat lymphoma but they would love SCIB1 big time and Scancell's ImmunoBody® technology even more. -- Lindy G. Durrant, Ph.D., Professor, Faculty of Medicine & Health Sciences and Chair in Cancer Immunotherapy, Department of Clinical Oncology, University of Nottingham (UK) -- An internationally recognized immunologist in the field of tumor therapy, Dr. Durrant has worked for more than 20-years in translational research, developing products for clinical trials including monoclonal antibodies for diagnostic imaging and therapy and cancer vaccines. She is currently running clinical trials in colorectal cancer, osteosarcoma and malignant melanoma. Biovest International, Inc. is an emerging leader in the field of active personalized immunotherapies. In collaboration with the National Cancer Institute, Biovest has developed a patient-specific, cancer vaccine, BiovaxID®, with three clinical trials completed, including a Phase III study, demonstrating evidence of safety and efficacy for the treatment of indolent follicular non-Hodgkin’s lymphoma. http://www.marketwatch.com/story/biovest-announces-international-members-of-its-cancer-vaccine-scientific-advisory-board-2012-04-03 http://www.accentia.net/

U dont have to trade this one, when scancell sell out, the fund will pay a massive dividend. so just forget about it ok... it will revalue once a year, in the portfolio Select and Scancell are the winners.

IMHO ... as there is always risk !!

nice one... buy and hold it will pay off !!

There is a miss match on SCLP Verse OXT…. OXT (OXT is a venture fund) last valuation of it’s portfolio was at 27p per share as of Nov 2011 the current market cap is £920,000 with a share price off 17p approx. but it holds as part of its portfolio 8,333,300 shares in Scancell The value at 17p = £1.41m plus. So the real value of this fund is well over £2,000,000 or 40p per share, every time Scancell jumps OXT should track it, but the market has NOT connected the two yet … get in while you can !!! http://www.oxfordtechnology.com/index.php?id=18&type=vct The un-audited net asset value per ordinary share as at 30 November 2011 was 27p. This is a rise of 1p from the last quarter ending 31 August 2011. The total number of ordinary shares in issue is 5,431,655 (As a footnote just it’s holding in Scancell = 26p per share) The spread is terrible, but that will tighten as MM excess stock gets bought up. Good luck all